Literature DB >> 15363437

The changing landscape of antiparasitic drug discovery for veterinary medicine.

Timothy G Geary, George A Conder, Bernard Bishop.   

Abstract

Changes in economic imperatives in the pharmaceutical industry have led to a wave of consolidation, which has had the unintended side effect of shrinking the resource devoted to antiparasitic drug discovery in animal health companies. Scientific changes have altered the way in which drugs could be discovered in the future. New science and business models will need to be implemented to address the demand for innovative antiparasitic drugs in veterinary medicine. Novel drugs are needed to combat drug resistance and for currently non-addressed problems. At the center of the future for this field, however, lies the need for more support into the basic research on the biology of parasites.

Mesh:

Substances:

Year:  2004        PMID: 15363437     DOI: 10.1016/j.pt.2004.08.003

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  13 in total

1.  Analysis of heavy-chain antibody responses and resistance to Parelaphostrongylus tenuis in experimentally infected alpacas.

Authors:  S R Purdy; L F Gagliardo; S Lefman; P J S Hamel; S Ku; T Mainini; G Hoyt; K Justus; L P Daley-Bauer; M S Duffy; J A Appleton
Journal:  Clin Vaccine Immunol       Date:  2012-05-16

Review 2.  Control of nematode parasites with agents acting on neuro-musculature systems: lessons for neuropeptide ligand discovery.

Authors:  Richard J Martin; Alan P Robertson
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  The nematode neuropeptide, AF2 (KHEYLRF-NH2), increases voltage-activated calcium currents in Ascaris suum muscle.

Authors:  S Verma; A P Robertson; R J Martin
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

Review 4.  The challenges of developing novel antiparasitic drugs.

Authors:  Debra J Woods; Tracey M Williams
Journal:  Invert Neurosci       Date:  2007-11-15

5.  Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer.

Authors:  Puranik Purushottamachar; Abhijit M Godbole; Lalji K Gediya; Marlena S Martin; Tadas S Vasaitis; Andrew K Kwegyir-Afful; Senthilmurugan Ramalingam; Zeynep Ates-Alagoz; Vincent C O Njar
Journal:  J Med Chem       Date:  2013-06-07       Impact factor: 7.446

6.  Experimental infection of Haemonchus contortus strains resistant and susceptible to benzimidazoles and the effect on mast cells distribution in the stomach of Mongolian gerbils (Meriones unguiculatus).

Authors:  Alzbeta Königová; Gabriela Hrckova; Samuel Velebný; Július Corba; Marián Várady
Journal:  Parasitol Res       Date:  2007-11-27       Impact factor: 2.289

Review 7.  Parasite neuropeptide biology: Seeding rational drug target selection?

Authors:  Paul McVeigh; Louise Atkinson; Nikki J Marks; Angela Mousley; Johnathan J Dalzell; Ann Sluder; Lance Hammerland; Aaron G Maule
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2011-11-15       Impact factor: 4.077

8.  Functional expression of parasite drug targets and their human orthologs in yeast.

Authors:  Elizabeth Bilsland; Pınar Pir; Alex Gutteridge; Alexander Johns; Ross D King; Stephen G Oliver
Journal:  PLoS Negl Trop Dis       Date:  2011-10-04

9.  Sorption of selected antiparasitics in soils and sediments.

Authors:  Andre Patrick Heinrich; Timm Zöltzer; Leonard Böhm; Manuel Wohde; Sara Jaddoudi; Yassine El Maataoui; Abdelmalek Dahchour; Rolf-Alexander Düring
Journal:  Environ Sci Eur       Date:  2021-07-02       Impact factor: 5.893

Review 10.  The Biology and Ecology of Cat Fleas and Advancements in Their Pest Management: A Review.

Authors:  Michael K Rust
Journal:  Insects       Date:  2017-10-27       Impact factor: 2.769

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.